TRIMAG COMPLEX Trademark

Trademark Overview


On Monday, December 30, 2024, a trademark application was filed for TRIMAG COMPLEX with the United States Patent and Trademark Office. The USPTO has given the TRIMAG COMPLEX trademark a serial number of 98928356. The federal status of this trademark filing is NON-FINAL ACTION - MAILED as of Thursday, March 27, 2025. This trademark is owned by Microbe Formulas, LLC. The TRIMAG COMPLEX trademark is filed in the Pharmaceutical Products category with the following description:

Dietary and nutritional supplements
trimag complex

General Information


Serial Number98928356
Word MarkTRIMAG COMPLEX
Filing DateMonday, December 30, 2024
Status641 - NON-FINAL ACTION - MAILED
Status DateThursday, March 27, 2025
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateNOT AVAILABLE

Trademark Statements


Goods and ServicesDietary and nutritional supplements

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateMonday, December 30, 2024
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameMicrobe Formulas, LLC
Party Type10 - Original Applicant
Legal Entity Type16 - Limited Liability Company
AddressMeridian, ID 83642

Trademark Events


Event DateEvent Description
Monday, December 30, 2024NEW APPLICATION ENTERED
Monday, December 30, 2024NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Tuesday, March 18, 2025ASSIGNED TO EXAMINER
Thursday, March 27, 2025NOTIFICATION OF NON-FINAL ACTION E-MAILED
Thursday, March 27, 2025NON-FINAL ACTION WRITTEN
Thursday, March 27, 2025NON-FINAL ACTION E-MAILED